CPHRF - Cipher Pharmaceuticals GAAP EPS of C$0.11 revenue of C$5.9M March, 17 2022 05:31 PM Companhia Siderurgica Paulista Nova Cosipa Cipher Pharmaceuticals press release (OTCPK:CPHRF): Q4 GAAP EPS of C$0.11. Revenue of C$5.9M (-3.3% Y/Y). For further details see: Cipher Pharmaceuticals GAAP EPS of C$0.11, revenue of C$5.9M